EKG Services Medical Policy
Defines coverage stance for electrocardiogram (ECG/EKG) diagnostic testing for BlueCHiP for Medicare and Commercial products, including when EKGs are covered (signs/symptoms/clinical indications) and that routine preventive screening in asymptomatic low-risk individuals is not recommended.
No material changes
Coverage Summary
Scope: This policy addresses coverage for EKG (Electrocardiogram) services for BlueCHiP for Medicare and Commercial products. Coverage stance: mixed — routine EKG screening is discouraged for asymptomatic, low-risk individuals, while EKGs are covered when there are documented signs, symptoms, or other clinical indications. Providers must document the clinical indication on the claim/medical record; when an EKG (CPT 93000) is filed with a preventive E&M code it is separately reimbursed only if filed with a diagnosis that supports medical necessity.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.